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INTRODUCTION

70
Human apolipoprotein-D (apoD) is a 169 amino acid glycoprotein member of the lipocalin family. In this 71 protein family, affiliation is not based on sequence homology but rather on structural homology 72 (Akerstrom et al., 2000) . The crystal structure of an apoD monomer reveals a typical lipocalin fold with 6 157 
162
BCF was applied neat or at the dilution described below to three formats of SEC; GE Superdex 200 163 16/600 (bed volume ~120 ml), GE Superdex 200 Increase 10/300 (bed volume ~24 ml), and a TOSOH 164 TSKgel Ultra SW Aggregate (bed volume ~14 ml). Fraction volumes collected were 2 ml (S200 16/600) 165 and 5 µl (S200 10/300). Superdex columns were equilibrated into buffer containing 25 mM Tris, 150 mM 166 NaCl, pH 8.0, using the Superdex 16/600 at a flow rate of 0.75 ml/min with a BCF injection volume of 167 200 µl, and the Superdex 10/300 at a flow rate of 0.5 ml/min with a BCF injection volume of 100 µl 168 (diluted 1:1 with buffer). TOSOH TSKgel Ultra SW Aggregate chromatography was performed using a 169 buffer containing 100 mM sodium phosphate, 100 mM sodium sulphate at pH 6.7 at a flow rate of 1.0 170 ml/min, and all samples (10 µl, BCF 1:20 dilution) were injected in triplicate. 
199
Ion exchange (IEX) chromatography purification of apoD was performed on a GE HiTrap ANX™
200
Sepharose FF 5 ml column equilibrated into IEX buffer (20mM piperazine, pH 5.0). BCF aliquots of 250 201 µL were applied to the column and eluted with a 0−50% gradient using high salt buffer (20 mM 202 piperazine, 1 M NaCl, pH 5.0) over 4 CV.
9
were dried, reactivated in methanol and stained using Ponceau S. The immunodetection procedure was 240 the same as described for SDS-PAGE but the apoD C1 antibody was used at a 1:1,000 dilution. for further analyses. All spectra that met these criteria were also manually visually verified: only 286 crosslinks with at least four fragment ions on both the alpha-and beta-chain peptide each and addressing 287 the most abundant peaks in the spectrum were retained for further analyses. Crosslinks that fulfilled all 288 these conditions were deemed unambiguous and high-confidence. Theoretical and experimental masses, 289 peptide sequences and how many times a specific crosslink was detected can be found in Table S2 .
291
Small angle X-ray scattering data collection and analysis 292 SEC-SAXS data in co-flow mode was collected at the SAXS/WAXS beamline at the Australian
293
Synchrotron, Melbourne, Australia. IEX-and SEC-purified apoD in SAXS-buffer (50 mM Na Phosphate, 294 150 mM NaCl, 3% (v/v) glycerol, pH 7.4) was spin-concentrated (7.5 mg/ml, measured by BCA assay) 295 and frozen at −80°C. Samples were thawed on ice and spun for 10 min at 16k × g before application of 50 296 µl to the GE Superdex 200 5/150 column which was equilibrated to SAXS-buffer. SAXS parameters are 297 described in 
305
To create models based on SAXS of the apoD tetramer, 21 conformations from a molecular dynamics 306 simulation of monomeric apoD with modelled glycosylation (Oakley et al., 2012) were used as starting 11 models. Two SASREF runs were performed to model a tetramer against the experimental SAXS data 308 with D 2 symmetry (P222 in SASREF). To restrain the model, the four unambiguously inter-subunit BS 3 309 crosslinks identified in XL-MS were used with a maximum distance of 32 Å (B2, B3, B4, B9, Table 1 ).
310
The maximum distance was set slightly longer than the theoretical maximum linker distance for BS 3 of 29 311 Å to allow for conformational flexibility of sidechains, rearrangement during oligomerisation as well as to 312 prevent the model becoming trapped in a conformation that it consistent with the cross-linking data, but 313 inconsistent with the SAXS data. The 42 produced SASREF models were visually inspected for fulfilling 314 the identified crosslinks, glycosylations interfering with the inter-subunit interface and obvious clashing 315 of glycosylations as SASREF only applies penalties for Cα-Cα clashes (Petoukhov and Svergun, 2005) .
316
Two SASREF models were then chosen based on their subunit conformation and according to the 317 evaluation of minimal steric clashing of glycosylations, glycosylation interference with the inter-subunit 318 interface and satisfying the identified crosslinks that were not restrained.
319
In parallel, the experimental SAXS data was used in DAMMIN with P222 symmetry to create 20 bead 320 models in each run. DAMAVER was used for validation and averaging with no model rejected in run 1 321 and two models rejected in run 2. Using the SUPALM, the filtered bead and SASREF models were 322 aligned and then superimposed in PyMOL. The superimposed SASREF models and the filtered ab initio 323 models were visually evaluated for how well they overlay.
325
Deglycosylation of apoD 326 IEX-purified apoD tetramer (0.05 µg) was deglycosylated using PNGase F (glycerol free, P0704L, New
327
England BioLabs) either under denaturing or native conditions according to the manufacturer's protocol.
328
For denaturing conditions, apoD tetramer was mixed with denaturing buffer, heated to 95°C for 5 min, 329 then glyco buffer, NP-40 and 1 µl PNGase were added and the reaction was incubated for 1 h at 37°C.
330
For native conditions, apoD was mixed with glyco buffer and 1.5 µl PNGase and the reaction was 331 incubated for 15 h, 24 h or 48 h at 37°C. Control samples were treated the same but PNGase was 332 substituted with ultrapure water. The complete sample volumes were analysed on denaturing SDS-PAGE 333 and western blotting as described above, with the difference that protein was transferred to nitrocellulose 334 membranes at 25 V for 90 min and detection was performed on Amersham X-ray films.
336
RESULTS
337
Characterisation of apoD in three human body fluids 338
Initial characterisation of apoD in plasma, BCF and CSF was undertaken by SDS-PAGE and western 339 blotting, with sample dilutions optimised for equal signal intensity (Figure 2A ). In BCF a single band at 340 approximately 27 kDa was detected, indicative of an apoD monomer. A similar molecular weight was 12 observed for apoD in CSF, while apoD in plasma was slightly larger at approximately 30 kDa. In BCF, a 342 second low abundance band at ~60 kDa was also immunoreactive to apoD antibody.
343
To assess potential oligomerisation of apoD in BCF, CSF and plasma, samples were analysed using blue 344 native (BN) and clear native (CN) PAGE and western blotting ( Figure 2B and C). Using BN PAGE, three 345 major bands were detected in BCF at ~130 kDa, 70 kDa and 45 kDa. Above and below this molecular 346 weight range, faint smeared bands were also observed. Furthermore, some apoD was present as high 347 molecular weight aggregates in the gel loading well. In contrast, CN PAGE of BCF showed a single band 348 at ~120 kDa, indicating an oligomeric apoD species. In CSF three bands were identified using BN PAGE,
349
with the main band at ~30 kDa and additional bands at 60 kDa and 100 kDa. This band pattern was not 350 present in CN PAGE, which showed bands around 600 kDa, 480 kDa and 300 kDa. In plasma, apoD in 351 BN PAGE did not enter the separating gel, indicating a very high molecular mass. Plasma analysed on 352 CN PAGE again showed an apoD band at a similarly high molecular weight, as well as some lower 353 molecular weight apoD bands.
354
The results of BN PAGE provided a strong indication that apoD is not exclusively present as a monomer 355 in BCF and CSF. Therefore, we analysed apoD oligomerisation in BCF and CSF in greater detail.
356
Four major protein bands were identified in BCF using SDS-PAGE Coomassie staining ( Figure 359 Haagensen et al., 1979) ; it is noteworthy that the major bands observed in the stained gel were consistent 360 with these four proteins. Western blotting again identified apoD as a predominant band at 27 kDa as well 361 as a second low abundance band at 60 kDa ( Figure 2D ).
362
To further evaluate apoD oligomerisation in BCF, initial SEC characterisation of BCF was performed 363 directly (<4 hr) after collection through application to a Superdex Increase 200 size exclusion 364 chromatography column (10 mm×300 mm). According to the elution profile depicted in Figure 2E , 365 samples of the main peaks 1-9 were analysed by SDS-PAGE with Coomassie staining ( Figure 2F ). The
366
predominant protein peak to elute from the column was identified as mainly apoD (peak 3). The retention 367 volume of peak 3 suggests a molecular mass of ~100 kDa, much larger than the theoretical ~25 kDa of a 368 monomeric 169 amino acid, fully glycosylated apoD. Notably, bands at the apparent molecular weight of 369 apoB-100 (515 kDa) or apoA-II (11 kDa) were not found at concentrations that are near stoichiometric 370 relevance for apoD. This indicates that the elution volume is not due to an association of apoD with 371 lipoprotein particles. Importantly, identical SEC results were obtained from fresh, non-frozen BCF as 372 from frozen BCF.
373
Using the same SEC column, SEC analysis was also performed on CSF resulting in the elution profile 374 shown in Figure 2G . No major peak at the exclusion volume (~8−10 ml) was detected, indicating no 375 13 dominant high-molecular weight complexes, which is in agreement with BN PAGE but not with CN 376 PAGE. SDS-PAGE western blot analysis of fractions within the range of the apoD monomer and 377 oligomers revealed that the major apoD fraction elutes at ~16.5 ml, corresponding to molecular weight of 378 apoD monomer ( Figure 2H ). Longer exposure to the CCD camera also showed less abundant apoD at 379 14.5 ml and 13 ml, which is consistent with the theoretical elution volume of apoD oligomers ( Figure S1 ).
380
The SEC analysis of CSF resembles the BN PAGE analysis but not the CN PAGE, since apoD was not 381 detected in SEC fractions eluting at a corresponding elution volume for proteins larger than 200 kDa (data 382 not shown). profile to the profile of protein standards suggested that the main apoD peak eluted at a volume consistent 399 with an oligomer of ~120 kDa.
400
Results from the large format S200 column confirmed the results obtained from BCF analysis on the 401 small SEC column and from BN PAGE. Specifically, the predominant fraction of apoD eluted from the 402 SEC column at a volume consistent with a hydrodynamic radius at least four-fold larger than expected of 403 monomeric apoD. To validate this result, SEC fractions were then applied to BN PAGE and analysed 404 both by Coomassie staining and western blotting ( Figure 2D and E). Coomassie staining ( Figure 2D) 405 revealed two major bands: A protein of ~120−140 kDa in peak 1 and ~70 kDa protein in peak 2. When 406 probed by western blot for apoD ( Figure 2E ), the 120 kDa band in peak 1 was the predominant band, 
415
To ascertain if this putative tetrameric apoD species was in dynamic equilibrium with other apoD 416 oligomeric species, S200 fractions containing the ~120 kDa apoD were pooled, concentrated and 417 reapplied to size exclusion columns in both the 10/300 and 16/600 format. The SEC chromatogram from 418 the 10/300 column is shown in Figure 4A . A single near-symmetric peak was observed with a retention 419 volume consistent with the proposed tetrameric apoD observed in BCF. SEC fractions of the peak were 420 analysed by SDS-PAGE with Coomassie staining. A distinct 27 kDa protein band was detected that was 421 accompanied by a low abundance band at ~60 kDa ( Figure 4B ). Both bands were confirmed as apoD by 422 western blotting ( Figure 4C) 
16
For size determination of the putative apoD tetramer, calibrated SEC columns were used to extrapolate a 429 molecular mass. Retention volumes for both apoD in BCF (Figure 3 peak 3) and purified apoD ( Figure 4) 430 from three different SEC column formats were obtained. In addition to the Superdex columns described 431 above, an HPLC-based TOSOH SEC column (~14 ml CV) was utilised. The HPLC column provided the 432 ability to generate data in triplicate as well as confirm the Superdex SEC data with an alternative 433 chromatographic media. Calibration curves and apoD results are shown in Figure S2 . The S200 Increase 434 10/300 was found to have the best statistical fit within the mass range of the size standards. The 
442
Purification of apoD by SEC alone did not yield in sufficient quantity and quality for further structural 443 analyses. Therefore, we used two parallel purification strategies, an established IEX-purification and a 444 novel HIC-purification, each with a subsequent SEC polishing step. To illustrate that these purification strategies did not affect the oligomeric status of apoD, we compare the elution profiles of BCF to SEC-,
446
IEX-and HIC-purified apoD ( Figure S3 ). The SEC elution volume of fresh, not freeze-thawed BCF was 447 consistent with SEC-purified apoD from frozen BCF and HIC-purified apoD (S200 10/300, Figure S3A ).
448
Furthermore, the SEC elution volume of BCF was consistent with IEX-purified apoD (S200 16/600, 449 Figure S3B ).
451
Crosslinking of apoD tetramer 452
The molecular weight determination of apoD oligomer using BN PAGE and SEC provided useful 453 approximate molecular mass values that were, however, variable to some degree. Therefore, we 
460
Crosslinked samples were analysed by SDS-PAGE and western blotting. Figure 5A 
475
Multi-angle laser light scattering (MALLS) analysis 476
For further verification of the apoD tetramer molecular weight, we applied HIC-and IEX-purified apoD 477 tetramer to a Superdex S200 10/300 column combined with MALLS (SEC-MALLS). From SEC-MALLS
478
( Figure 6A ) a single, near-symmetrical peak of apoD eluted at a volume corresponding to a tetramer, 479 consistent with the initial SEC characterisation (Figure 3) . The observed experimental molecular weight 480 of apoD, weight-averaged from three separate runs, was 93.6 ± 3.7 kDa which is consistent with an apoD 481 tetramer. Interestingly, the MALLS analysis indicated a molecular weight ranging from 110 kDa to 85 482 kDa over the elution peak and the light scattering signal slightly preceded the UV and differential 483 refractive index measurement ( Figure 6A ). This shift in the light scattering signal can indicate that the 484 apoD peak may not be entirely homogeneous, e.g. due to varying degrees of apoD glycosylation. This 485 was tested by SDS-PAGE western blot analysis of collected MALLS fractions which demonstrated 486 consistent apparent molecular weight of the monomer units within the apoD tetramer ( Figure 6B) . Therefore, the apparent heterogeneity of apoD tetramer based on the light scattering profile and the 488 observed range of molecular sizes is not due to differences in gross glycan content. 
495
Sedimentation velocity of tetrameric apoD was measured at a range of apoD concentrations from 0.08 496 mg/ml to 0.8 mg/ml and the normalised distribution of sedimentation coefficients is shown in Figure 6C . Table S1 . Post-collection analysis 517 of the radius of gyration (R g ) and scattering intensity I(0) over the SEC peak determined the region of 518 constant R g for averaging and further analysis (marked in red, Figure 7A ). After averaging and buffer 519 subtraction, the data was evaluated in the Guinier region ( Figure 7B) . The data at small q values did not Figure 7C . All experimental and calculated parameters are listed in Table S1 . For the 524 experimental values, the I(q) versus q profile was transformed to a P(r) function shown in Figure 7D . P(r) 525 corresponds to the probable distribution of vector lengths (r) between scattering centres within the 526 scattering molecule and can be used to determine approximate shape and size of scattering molecules. The 527 P(r) profile of tetrameric apoD corresponded to a globular shaped molecule, with a Porod volume of 528 169000 Å 3 . Based on the Porod volume, apoD molecular weight was estimated to be 99 kDa. This is in 529 good agreement with molecular weight determination based on I(0) which is 97.1 kDa. Therefore, SEC-
530
SAXS of oligomeric apoD further supports the tetrameric state of apoD. Additionally, the Kratky plot in 531 Figure S5A showed a bell-shaped curve indicating that the apoD tetramer has a globular shape. 
539
To gain more insight into the tetrameric structure of apoD, we utilised XL-MS to obtain distance 540 information. Purified apoD was crosslinked with either BS 3 (crosslinks primary amines), ADH (crosslinks 541 carboxylic acids) or DMTMM, a side-reaction in the ADH crosslinking experiment, which crosslinks 542 primary amines to carboxylic acids. DMTMM catalysed reactions will be referred to as 'ZLXL' (zero- Table 1 and their respective MS spectra are shown in Figure S6 .
553
Out of these 13 crosslinks, four crosslinks (Table 1, crosslinks B2, B3, B4 and B9) were found to be 554 unambiguously inter-subunit. This was based on the observation that the crosslink was either identified 555 between identical residues (B2: K55-K55 and B3: K156-K156) or between residues derived from 556 peptides with overlapping sequences (B4: peptide 1 (residues 156-169) crosslinked to peptide 2 (residues 557 145-156), and B9: peptide 1 (residues 132-156) crosslinked to peptide 2 (residues 156-167)). For these 558 crosslinks to occur, the peptides must have originated from two apoD monomers. In addition, three 559 crosslinks (Table 1 , crosslinks B7, Z2 and Z3) were also noted to be possibly inter-subunit crosslinks 560 rather than intra-subunit; the measured intra-subunit crosslinker lengths for these three crosslinks exceed 561 the theoretical length of the crosslinker. To further our structural understanding of tetrameric apoD, we applied an ab initio modelling approach 569 using DAMMIN to produce low-resolution shapes with P222 symmetry for the tetrameric structure based 570 on the SAXS data. The two filtered models are shown in Figure S5 B and exhibit no major differences in 571 shape (model 1, orange: Normalised spatial discrepancy (NSD) = 1.315 ± 0.077; model 2, cyan: NSD = 572 1.203 ± 0.105).
573
In parallel, monomeric models of apoD high-resolution X-ray structure (Eichinger et al., 2007) with 574 different modelled glycosylation conformations (Oakley et al., 2012) were used as rigid bodies for 575 SASREF modelling. We assumed a D 2 symmetry since D 2 is a very common symmetry for a tetramer 576 (Goodsell and Olson, 2000) . A C 4 symmetry is another possible symmetry for a tetramer, however, 577 models with C 4 symmetry had a worse fit with the experimental scattering data (χ 2 > 2.1, data not shown).
578
We chose the unambiguously inter-subunit BS 3 crosslinks B2, B3, B4 and B9 as restraints in the 579 modelling of the apoD tetramer, as BS 3 crosslinking was also experimentally tested to not introduce 580 aggregation of apoD ( Figure 5 ). Two rounds of SASREF modelling using all 21 glycosylation 581 conformations (Oakley et al., 2012) were performed and the resulting models were visually evaluated and 582 selected based on minimal steric clashing of glycosylations, glycosylation interference with the inter-583 subunit interface and satisfying the identified crosslinks that were not restrained.
584
Two global subunit conformations resulted from the modelling process. One representative model for 
588
This agreement is also highlighted by the error-weighted residual difference plots (I exp (q) − I calc (q))/σ exp (q) 24 vs q) in the lower panel in Figure 7C : The residual plot shows a flat curve without pronounced deviation,
590
including in the high q area.
591
Finally, the rigid-body tetramer models were structurally aligned with ab initio model 2 which produced a 592 better overlay than ab initio model 1. 
693
In other lipocalins, ligand binding (Gutierrez-Magdaleno et al., 2013) or pH (Mans and Neitz, 2004; Qin 694 et al., 1998) have been shown to influence oligomerisation. Since ligand binding of apoD may play a role 695 in inflammation and oxidative stress and, therefore, in AD due to binding to AA and other lipids (Bhatia et al., 2013; Phillis et al., 2006) , apoD oligomerisation could potentially influence these functions and 697 lead to differentiated behaviour of apoD. Recently, apoD was shown to protect vulnerable lysosomes 698 from oxidative stress and was found to be located on the inside of lysosomes, where pH is low, and to 699 maintain ligand binding (Pascua-Maestro et al., 2017) . Therefore, it could be interesting in future to 700 assess the oligomeric structure of intralysosomal apoD.
696
701
Our SAXS experiments further confirmed the presence of an apoD tetramer, with a calculated molecular 702 weight of 99 kDa and proposed a globular structure (Figure 7 and S5) . Additionally, we provide structural 703 insight into the apoD tetramer. ApoD model 1 showed stacked antiparallel β-barrels and stacked adjacent 
711
respectively. Furthermore, the so-called 'spike', located at the bottom of the apoD ligand binding pocket, 712 is exposed in both models. This area has been implicated in binding to basiginin, a potential receptor for 713 apoD internalisation (Najyb et al., 2015) .
714
In summary, our data revealed that apoD predominantly forms tetramers in BCF and that apoD 715 oligomerisation also takes place in CSF. 
